JMP Securities upgraded shares of Medical Properties Trust, Inc. (NYSE:MPW) from a market perform rating to an outperform rating in a report issued on Monday. The brokerage currently has $14.00 price target on the real estate investment trust’s stock. The analysts noted that the move was a valuation call.
Several other research firms also recently weighed in on MPW. Jefferies Group LLC upgraded Medical Properties Trust from a hold rating to a buy rating and boosted their price target for the company from $13.00 to $15.00 in a research note on Friday, April 7th. Deutsche Bank AG boosted their price target on Medical Properties Trust from $13.50 to $15.00 and gave the company a buy rating in a research note on Thursday, April 6th. Royal Bank Of Canada reiterated a buy rating on shares of Medical Properties Trust in a research note on Monday, May 15th. ValuEngine downgraded Medical Properties Trust from a buy rating to a hold rating in a research note on Friday, June 2nd. Finally, BidaskClub upgraded Medical Properties Trust from a sell rating to a hold rating in a research note on Saturday, June 10th. Three analysts have rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the stock. Medical Properties Trust has an average rating of Hold and an average target price of $14.30.
Shares of Medical Properties Trust (MPW) opened at 13.04 on Monday. The stock has a market capitalization of $4.19 billion, a PE ratio of 15.65 and a beta of 0.89. Medical Properties Trust has a 52 week low of $11.54 and a 52 week high of $15.92. The company has a 50-day moving average price of $13.03 and a 200 day moving average price of $13.02.
Medical Properties Trust (NYSE:MPW) last announced its earnings results on Thursday, May 4th. The real estate investment trust reported $0.33 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.33. Medical Properties Trust had a return on equity of 7.94% and a net margin of 41.79%. The firm had revenue of $156.40 million for the quarter, compared to the consensus estimate of $156.91 million. During the same period in the previous year, the business earned $0.35 EPS. The firm’s revenue for the quarter was up 15.9% on a year-over-year basis. Equities analysts forecast that Medical Properties Trust will post $0.87 EPS for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Medical Properties Trust, Inc. (MPW) Upgraded to “Outperform” at JMP Securities” was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another site, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this news story can be viewed at https://sportsperspectives.com/2017/07/19/medical-properties-trust-inc-mpw-upgraded-to-outperform-at-jmp-securities.html.
The business also recently announced a quarterly dividend, which was paid on Friday, July 14th. Stockholders of record on Thursday, June 15th were paid a $0.24 dividend. The ex-dividend date of this dividend was Tuesday, June 13th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.36%. Medical Properties Trust’s payout ratio is 114.29%.
In other news, CFO R Steven Hamner sold 85,000 shares of the company’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 1.00% of the stock is owned by corporate insiders.
Hedge funds have recently modified their holdings of the company. Macquarie Group Ltd. boosted its position in Medical Properties Trust by 3.9% in the fourth quarter. Macquarie Group Ltd. now owns 253,400 shares of the real estate investment trust’s stock worth $3,116,000 after buying an additional 9,400 shares during the last quarter. Cubic Asset Management LLC boosted its position in Medical Properties Trust by 1.4% in the first quarter. Cubic Asset Management LLC now owns 196,690 shares of the real estate investment trust’s stock worth $2,535,000 after buying an additional 2,675 shares during the last quarter. Naples Global Advisors LLC boosted its position in Medical Properties Trust by 35.1% in the first quarter. Naples Global Advisors LLC now owns 24,830 shares of the real estate investment trust’s stock worth $320,000 after buying an additional 6,450 shares during the last quarter. State of Alaska Department of Revenue boosted its position in Medical Properties Trust by 35.0% in the first quarter. State of Alaska Department of Revenue now owns 160,060 shares of the real estate investment trust’s stock worth $2,062,000 after buying an additional 41,530 shares during the last quarter. Finally, Raymond James Trust N.A. acquired a new position in Medical Properties Trust during the first quarter worth $154,000. Hedge funds and other institutional investors own 78.45% of the company’s stock.
About Medical Properties Trust
Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.
Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.